Design Therapeutics, Inc. DSGN Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$69.79M-40.7% | -$49.59M+25.8% | -$66.86M-5.6% | -$63.31M-78.2% | ||
| $622K+4.4% | $596K+11.0% | $537K+32.3% | $406K+215% | ||
| $14.55M+11.3% | $13.07M-0.1% | $13.09M+19.8% | $10.93M+133% | ||
| -$54.36M-26.1% | -$43.11M+26.4% | -$58.56M-14.1% | -$51.32M-74.7% | ||
| $193K— | —— | $256K-72.1% | $918K-40.3% | ||
| —— | —— | $52.54M+124% | -$220.99M-312% | ||
| $25.74M+4,917% | $513K— | —— | $235K-99.9% | ||
| —— | —— | -$5.3M+98.1% | -$272.07M— | ||
| -$54.55M-25.6% | -$43.45M+26.1% | -$58.82M-12.6% | -$52.24M-69.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Design Therapeutics, Inc. generate?
- Design Therapeutics, Inc. (DSGN) generated -$54.0M in operating cash flow over the trailing twelve months.
- What is Design Therapeutics, Inc.'s free cash flow?
- After $121.0K of capital expenditures, Design Therapeutics, Inc.'s free cash flow was -$54.1M over the trailing twelve months, down 13.5% year over year.
- Where does Design Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Design Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.